INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, increase (decrease) for assets transferred to (from) plan for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, increase (decrease) for assets transferred to (from) plan for fiscal 2024 was $322.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, plan assets, increase (decrease) for assets transferred to (from) plan for fiscal 2023 was $0.00.
| Period end | Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $322.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |